Nueva designación en el NIH
The NIH has appointed Dr. John Gaitanis, a pediatric neurologist known for his controversial views on autism, to lead the agency’s child health institute. This decision has sparked discussions within the medical community due to his differing perspectives on autism management and research.
Menopausia y volumen cerebral
A recent cohort study published in JAMA Network Open highlights a correlation between age at menopause and brain volume trajectory in older women, suggesting that hormonal changes may have lasting effects on brain health.
Supervivientes de hemorragia subaracnoidea
Young survivors of aneurysmal subarachnoid hemorrhage are at a significant lifelong risk for developing new aneurysms, with a recent study indicating that these risks do not plateau even after four decades.
Aprobación de nueva inyección para Alzheimer
The FDA has approved florquinitau F 18 injection (Tauklarify), which is a tau PET imaging agent designed to aid in the diagnosis of Alzheimer’s disease, according to an announcement by Lantheus.
Interrupción de ensayo clínico
The FDA has placed a clinical hold on a trial involving the investigational gene therapy clemidsogene lanparvovec (RGX-121) for mucopolysaccharidosis (MPS) type II, commonly known as Hunter syndrome, due to the discovery of asymptomatic small masses in the spines of five patients.
Investigación en MPS tipo IIIA
Recent findings suggest that drug screening and machine learning techniques may identify potential neuroprotective agents for MPS type IIIA, also known as Sanfilippo syndrome, which affects children and is characterized by progressive neurological decline.
Uso de benzodiazepinas en emergencias
Experts are advocating for the inclusion of benzodiazepines in airline emergency medical kits, highlighting their importance in managing inflight seizures, according to JAMA Neurology.
Valproato y riesgo de autismo
Data from Taiwan indicates that fathers who have used the antiseizure drug valproate before conception are not at a higher risk of having children with autism or ADHD compared to those who have not used the medication.
Rutas de desarrollo hacia el autismo
A longitudinal study in children with tuberous sclerosis complex reveals potential developmental pathways to autism, providing crucial insights for early diagnosis and intervention.
Nueva terapia subcutánea para Alzheimer
Eisai has announced the availability of a once-weekly lecanemab subcutaneous injection for the initiation of therapy in adults experiencing mild cognitive impairment or mild dementia due to Alzheimer’s disease, following its recent approval.
Disclaimer: La información proporcionada en este artículo es únicamente con fines informativos y no debe considerarse como consejo médico. Siempre consulte a un profesional de salud calificado para obtener asesoramiento sobre condiciones médicas específicas.
Fuente: https://www.medpagetoday.com/neurology/generalneurology/122750
Join the doctors who get the most relevant medical news, curated by specialty, every week — no spam, unsubscribe anytime.
